Trusted Insighthttp://thetrustedinsight.com/2024-01-04T08:31:06.756151-05:00Trusted Insight, the world's largest platform for institutional investors with 40,000 LP investor professionals in 98 countries and territories around the globe. 30,000 institutional investors engage with Trusted Insight each week. They are actively investing in alternative assets, primarily private equity, hedge funds, real estate and private companies. Our users consist of pension funds, endowments, foundations, sovereign wealth funds, family offices, banks and insurance companies. 83% of Trusted Insight users continue to use the platform 6 months after initially signing up. Investors on the platform, on average manage in excess of $5 billion. We are a platform for qualified purchasers, not high net worth investors.
Goldman Sachs Asset Management Raises $650M For Life Sciences I Fund, Targets Innovation - Goldman Sachs Gr (nyse:gs)
2024-01-04T08:31:06.756151-05:00https://www.thetrustedinsight.com/investment-news/goldman-sachs-asset-management-raises-650m-for-life-sciences-i-fund-targets-innovation-goldman-sachs-gr-nysegs-20240104865/
The Goldman Sachs Group Inc's (NYSE: GS) Goldman Sachs Asset Management recently read more. :
The Goldman Sachs Group Inc's GS Goldman Sachs Asset Management recently disclosed the closure of the West Street Life Sciences I fund. The company stated that Life Sciences I closed above its fundraising target with $650 million in equity commitments. The fund represents the first in the firm's Life Sciences Investing strategy and is one of the largest ever first-time private life sciences growth funds. The fund is managed by Goldman Sachs Asset Management's Life Sciences Investing Group, established in 2021 and led by Amit Sinha.
Healthcare & Life Sciences Private Equity Deal Tracker: Gryphon Sells Potter To Kkr | Mcguirewoods Llp
2023-12-14T16:01:06.102469-05:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-gryphon-sells-potter-to-kkr-mcguirewoods-llp-20231214230/
Gryphon Investors has announced it has sold Potter Global Technologies to investment funds managed by KKR. Potter, based in St. Louis, Mo., is global provider of fire safety and emergency communication products....By: McGuireWoods LLP.
Bain, Kkr, Advent Circle Sai Life Sciences
2023-12-07T20:01:18.079426-05:00https://www.thetrustedinsight.com/investment-news/bain-kkr-advent-circle-sai-life-sciences-20231207937/
Both TPG and its current promoter Krishna Kanumuri may sell stakes as part of the transaction. :
Mumbai: Global private equity funds, including Bain Capital, KKR, and Advent International, are in talks for a controlling stake in Sai Life Sciences at a valuation of $600-700 million, three people aware of the development said. Sai Life Sciences (SLS) is a Hyderabad-based pharmaceutical contract research and development, and manufacturing (CRDMO) firm.
Healthcare & Life Sciences Private Equity Deal Tracker: Lovell Minnick Acquires S&s Health | Mcguirewoods Llp
2023-10-09T16:31:17.517447-04:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-lovell-minnick-acquires-ss-health-mcguirewoods-llp-20231009479/
Lovell Minnick Partners (LMP) has announced it has completed a majority investment in S&S Health....By: McGuireWoods LLP. :
Lovell Minnick Partners (LMP) has announced it has completed a majority investment in S&S Health. S&S, founded in 1994 and based in Mason, Ohio, is a healthcare administration company providing solutions for health plans for small and mid-sized businesses. LMP, based in Rednor, Pa., is private equity firm which seeks to invest in growth-oriented financial services and financial technology companies. Founded in 1999, the firm generally makes equity investments between $40 million and $150 million.
Preventative Health And Longevity Company, Viome Life Sciences, Closes $86.5M Oversubscribed Series C Funding Round
2023-08-18T09:11:06.361670-04:00https://www.thetrustedinsight.com/investment-news/preventative-health-and-longevity-company-viome-life-sciences-closes-865m-oversubscribed-series-c-funding-round-20230818372/
The additional financing supports the further development of its suite of advanced personalized health tests and expansion into key nationwide retailers such as CVS BELLEVUE, Wash., Aug. 18, 2023 /PRNewswire/ -- Viome Life Sciences, a longevity company committed to translating scientific...
Life Sciences Real Estate Update - 3.21.23 | Allen Matkins
2023-03-23T13:01:27.870493-04:00https://www.thetrustedinsight.com/investment-news/life-sciences-real-estate-update-32123-allen-matkins-20230323407/
Despite a strong start last year, venture capital funding for life sciences totaled $35.8 billion in 2022, down 28% from 2021, according to Cushman & Wakefield (C&W). Initial public offering activity also fell 90% from $14.5 billion in 2021 to $1.4 billion in 2022....By: Allen Matkins.
Life Sciences Real Estate Update - 2.08.23 | Allen Matkins
2023-02-09T14:01:15.305458-05:00https://www.thetrustedinsight.com/investment-news/life-sciences-real-estate-update-20823-allen-matkins-20230209123/
Last year’s solid venture capital investment in life sciences was, as expected, focused on the big three markets of San Diego, Boston, and San Francisco. But as a recent Cushman & Wakefield report found, emerging markets saw significant spikes of interest, perhaps suggesting a shift toward building startups and more lab space outside established markets....By: Allen Matkins.
Catalio Capital Management Launches Long-short Public Equities Strategy Focused On Global Healthcare And Life Sciences Sectors | Business Wire
2023-01-04T09:01:40.826881-05:00https://www.thetrustedinsight.com/investment-news/catalio-capital-management-launches-long-short-public-equities-strategy-focused-on-global-healthcare-and-life-sciences-sectors-business-wire-20230104626/
NEW YORK--(BUSINESS WIRE)--Catalio Capital Management, LP (“Catalio”), a leading multi-strategy life sciences investment firm with more than $1 billion in assets under management, today announced the launch of its dedicated public equities hedge fund investment strategy focused on identifying compelling life science investment opportunities globally. In connection with the launch of the vehicle, the seasoned investment team from HealthCor Management (“HealthCor”), a well-established healthcare.
Healthcare & Life Sciences Private Equity Deal Tracker: Viewside Capital And Morningside Invest In Resilience Lab | Mcguirewoods Llp
2022-11-29T13:01:06.950822-05:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-viewside-capital-and-morningside-invest-in-resilience-lab-mcguirewoods-llp-20221129246/
Viewside Capital Partners and Morningside Group have co-led a $15 million series A funding round in Resilience Lab, according to a news release. Resilience Lab, based in New York, is a mental health technology company....By: McGuireWoods LLP.
Jpmorgan Chase Hires Orbimed Advisors Executive For New Life Sciences Venture Capital Unit
2022-11-01T19:01:16.263556-04:00https://www.thetrustedinsight.com/investment-news/jpmorgan-chase-hires-orbimed-advisors-executive-for-new-life-sciences-venture-capital-unit-20221101932/
JPMorgan Chase & Co. said Tuesday its J.P. Morgan Asset Management unit is launching a new private capital team aimed at investments in life sciences. Stephen Squinto is now chief investment officer and managing partner of Life Sciences Private Capital for the bank. He previously worked at private equity firm OrbiMed Advisors. Squinto was also co-founder of Alexion Pharmaceuticals, now a unit of AstraZeneca PLC and was a scientific founder of Regeneron Pharmaceuticals . Gaurav Gupta and Anya Schiess are co-managing partners.
Healthcare & Life Sciences Private Equity Deal Tracker: Avista Acquires Wellspring Consumer From Audax | Mcguirewoods Llp
2022-08-25T14:31:17.333230-04:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-avista-acquires-wellspring-consumer-from-audax-mcguirewoods-llp-20220825727/
Avista Capital Partners has acquired WellSpring Consumer Healthcare from Audax Private Equity, according to a news release. WellSpring, founded in 1999 and based in Sarasota, Fla., markets over-the-counter drug and personal care products to the U.S. and Canadian markets....By: McGuireWoods LLP.
Barings Acquires Bay Area Life Science Portfolio
2022-06-28T15:01:10.498959-04:00https://www.thetrustedinsight.com/investment-news/barings-acquires-bay-area-life-science-portfolio-20220628160/
Three GMP Buildings in Fremont, California
Acquisition Executes on Firm's Growth in Specialized Asset Class
CHARLOTTE, N.C., June 28, 2022 /PRNewswire/ -- Barings, one of the world's largest diversified real estate investment managers, announced today its acquisition of a portfolio of three life science assets totaling 228,025 square feet in Fremont, California from Angelo Gordon & Company. Lincoln Property Company has joined Barings in the venture, and Newmark has facilitated the transaction.
Healthcare & Life Sciences Private Equity Deal Tracker: Berkshire Partners And Warburg Pincus Invest In Ensemble Health | Mcguirewoods Llp
2022-04-05T15:31:06.442878-04:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-berkshire-partners-and-warburg-pincus-invest-in-ensemble-health-mcguirewoods-llp-20220405067/
Berkshire Partners and Warburg Pincus have agreed to invest in Ensemble Health Partners, according to a news release. Ensemble, based in Cincinnati, Ohio, is a provider of technology-enabled revenue cycle management solutions for health systems....By: McGuireWoods LLP.
Life Sciences And Healthcare Leader Concertai Raises $150 Million Series C From Sixth Street At $1.9B Valuation
2022-03-29T07:16:07.248945-04:00https://www.thetrustedinsight.com/investment-news/life-sciences-and-healthcare-leader-concertai-raises-150-million-series-c-from-sixth-street-at-19b-valuation-20220329691/
ConcertAI SaaS and data solutions have rapidly emerged as the industry standard for accelerating clinical trials and patient outcomes CAMBRIDGE, Mass., March 29, 2022 /PRNewswire/ -- ConcertAI, LLC (ConcertAI), the leader in enterprise AI and real-world data (RWD) solutions for life...
Healthcare & Life Sciences Private Equity Deal Tracker: Gtcr Acquires Experity | Mcguirewoods Llp
2022-03-04T16:31:06.708613-05:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-gtcr-acquires-experity-mcguirewoods-llp-20220304506/
GTCR has announced it has acquired a majority equity stake in Experity. Experity, based in Machesney Park, Ill., is a provider of SaaS software solutions and technology-enabled services for the urgent care industry....By: McGuireWoods LLP.
Newpath Partners Launches Fund Ii To Create Life Sciences Companies
2021-12-09T06:01:29.913408-05:00https://www.thetrustedinsight.com/investment-news/newpath-partners-launches-fund-ii-to-create-life-sciences-companies-20211209765/
List of Venture Capital / Private Equity Firms and Sources
Published since 1998, VCPro
Database is the most reliable, up-to-date and affordable venture
capital directory
2021 EDITION SPECIAL OFFER! Buy Now for only $119.95 plus a FREE update in January
2022
Learn More
or
Buy Now
VCPro Database 2021
24th Edition --
a downloadable and searchable venture capital database with
6,500+ venture capital and private equity firms
worldwide.
Report: Life Sciences Sector Is Booming As Companies Swoop Up Lab Space And Raise Gobs Of Cash
2021-12-08T06:01:12.303063-05:00https://www.thetrustedinsight.com/investment-news/report-life-sciences-sector-is-booming-as-companies-swoop-up-lab-space-and-raise-gobs-of-cash-20211208669/
It’s hard for life sciences startups to find lab space, and there’s a good reason. The sector has been on a tear, according to a report tallying venture capital and real estate transactions in Seattle and other life science clusters within the last year. Venture capital funding for the life sciences hit record highs nationally, reaching more than $30 billion in the year through September, according to the report by real estate firm CBRE. And while major clusters such as Boston reeled in billions, the Seattle area pulled in a whopping $898 million.
Healthcare & Life Sciences Private Equity Deal Tracker: Advent International Invests In Iodine Software | Mcguirewoods Llp
2021-12-03T15:31:22.301042-05:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-advent-international-invests-in-iodine-software-mcguirewoods-llp-20211203433/
Advent International has made a strategic growth investment in Iodine Software, according to a news release. Iodine, based in Austin, Texas, is the developer of a clinical AI solution designed to support the accurate capture of patient documentation....By: McGuireWoods LLP.
Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital To Invest In Innovacare Health | Mcguirewoods Llp
2021-11-29T12:01:26.251325-05:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-bain-capital-to-invest-in-innovacare-health-mcguirewoods-llp-20211129092/
Bain Capital Private Equity has announced it will acquire a majority stake in InnovaCare Health. InnovaCare, based in White Plains, N.Y., is a provider of integrated and value-based healthcare services....By: McGuireWoods LLP.
Cfius Concerns In Life Science Investment And Venture Capital Transactions | Morgan Lewis
2021-11-16T20:01:16.433519-05:00https://www.thetrustedinsight.com/investment-news/cfius-concerns-in-life-science-investment-and-venture-capital-transactions-morgan-lewis-20211116387/
There has been a significant increase in cross-border investment (FDI) in the US life sciences industry, including both medtech and biopharmaceutical companies. Determining if life sciences companies, particularly those in the venture capital and start-up communities, have “critical technology” or “sensitive personal data” that would trigger CFIUS-filling can be a fact-intensive exercise because it involves determining if an export license would be required for the foreign investor(s) in...By: Morgan Lewis.
Nea Welcomes Veteran Life Sciences Investor Michele Park As Partner On Its Healthcare Investing Team
2021-11-05T07:01:10.399355-04:00https://www.thetrustedinsight.com/investment-news/nea-welcomes-veteran-life-sciences-investor-michele-park-as-partner-on-its-healthcare-investing-team-20211105672/
List of Venture Capital / Private Equity Firms and Sources
Published since 1998, VCPro
Database is the most reliable, up-to-date and affordable venture
capital directory
2021 EDITION SPECIAL OFFER! Buy Now for only $119.95 plus a FREE update in January
2022
Learn More
or
Buy Now
VCPro Database 2021
24th Edition --
a downloadable and searchable venture capital database with
6,500+ venture capital and private equity firms
worldwide.
Healthcare & Life Sciences Private Equity Deal Tracker: Gi Partners And Ta Associates Invest In Rectangle Health | Mcguirewoods Llp
2021-11-04T15:01:06.378480-04:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-gi-partners-and-ta-associates-invest-in-rectangle-health-mcguirewoods-llp-20211104634/
GI Partners and TA Associates have recapitalized Rectangle Health, according to a news release. Rectangle Health, based in Valhalla, N.Y., is a provider of healthcare financial technology and patient engagement solutions....By: McGuireWoods LLP.
Frazier Healthcare Closes $830M Life Sciences Fund | Mcguirewoods Llp
2021-11-01T14:11:05.768617-04:00https://www.thetrustedinsight.com/investment-news/frazier-healthcare-closes-830m-life-sciences-fund-mcguirewoods-llp-20211101358/
Frazier Healthcare Partners has announced the closing of its first dedicated public life sciences fund. Frazier Life Sciences Public Fund is closing on nearly $830 million in capital commitments, which exceeds its target. It is a long-only fund that will invest in small- and mid-cap public biotech companies....By: McGuireWoods LLP.
Frazier Healthcare Partners Closes Oversubscribed $830M Life Sciences Public Fund
2021-10-28T22:46:07.699972-04:00https://www.thetrustedinsight.com/investment-news/frazier-healthcare-partners-closes-oversubscribed-830m-life-sciences-public-fund-20211028214/
List of Venture Capital / Private Equity Firms and Sources
Published since 1998, VCPro
Database is the most reliable, up-to-date and affordable venture
capital directory
2021 EDITION SPECIAL OFFER! Buy Now for only $119.95 plus a FREE update in January
2022
Learn More
or
Buy Now
VCPro Database 2021
24th Edition --
a downloadable and searchable venture capital database with
6,500+ venture capital and private equity firms
worldwide.
Healthcare & Life Sciences Private Equity Deal Tracker: Wellspring Acquires Caring Brands From Levine Leichtman | Mcguirewoods Llp
2021-10-27T15:31:15.583936-04:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-wellspring-acquires-caring-brands-from-levine-leichtman-mcguirewoods-llp-20211027116/
Wellspring Capital Management has acquired Caring Brands International from Levine Leichtman Capital Partners, according to this news release and this news release....By: McGuireWoods LLP.
Monika Vnuk And Matt Lane Join Blackstone Life Sciences As Managing Directors
2021-10-14T07:31:38.626731-04:00https://www.thetrustedinsight.com/investment-news/monika-vnuk-and-matt-lane-join-blackstone-life-sciences-as-managing-directors-20211014305/
List of Venture Capital / Private Equity Firms and Sources
Published since 1998, VCPro
Database is the most reliable, up-to-date and affordable venture
capital directory
2021 EDITION SPECIAL OFFER
Buy Now for only $119.95 plus a FREE 2022 update in January
2022
Learn More
or
Buy Now
VCPro Database 2021
24th Edition --
a downloadable and searchable venture capital database with
6,500+ venture capital and private equity firms
worldwide.
Frazier Healthcare Partners Adds Highly Experienced Biopharmaceutical Executive To Life Sciences Team
2021-09-22T22:31:10.325933-04:00https://www.thetrustedinsight.com/investment-news/frazier-healthcare-partners-adds-highly-experienced-biopharmaceutical-executive-to-life-sciences-team-20210922919/
List of Venture Capital / Private Equity Firms and Sources
Published since 1998, VCPro
Database is the most reliable, up-to-date and affordable venture
capital directory
2021 NEW EDITION NOW AVAILABLE! Buy Now for $119.95 with a free annual update in January
2022
Learn More
or
Buy Now
VCPro Database 2021
24th Edition --
a downloadable and searchable venture capital database with
6,500+ venture capital and private equity firms
worldwide.
Healthcare & Life Sciences Private Equity Deal Tracker: Patient Square To Acquire Summit Bhc From Ffl Partners And Lee Equity | Mcguirewoods Llp
2021-09-09T13:31:16.528834-04:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-patient-square-to-acquire-summit-bhc-from-ffl-partners-and-lee-equity-mcguirewoods-llp-20210909987/
Patient Square Capital will acquire Summit BHC from FFL Partners and Lee Equity Partners, according to a news release. Summit BHC, based in Franklin, Tenn., develops and operates behavioral health hospitals and addiction treatment centers throughout the country. Founded in 2013, the company’s primary focus is on psychiatric services and substance use disorder treatment....By: McGuireWoods LLP.
Reliance Life Sciences Seeks Nod To Start Human Trials Of Covid-19 Vaccine: Report
2021-08-26T07:01:10.515190-04:00https://www.thetrustedinsight.com/investment-news/reliance-life-sciences-seeks-nod-to-start-human-trials-of-covid-19-vaccine-report-20210826082/
The unlisted firm’s parent Reliance Industries did not immediately respond to a Reuters request for comment. :
Pre-configured baskets of stocks & ETFs that you can invest in with a single click. Developed by hedge funds, global asset management companies, experienced wealth management firms and portfolio managers. Curated markets data, exclusive trading recommendations, Independent equity analysis & actionable investment ideas India’s Reliance Life Sciences has applied for regulatory approval to begin early stage human trials of its COVID-19 vaccine candidate, The Economic Times reported on Thursday.
Sands Capital Closes $560M Life Sciences Fund
2021-08-09T21:31:19.204127-04:00https://www.thetrustedinsight.com/investment-news/sands-capital-closes-560m-life-sciences-fund-20210809075/
List of Venture Capital / Private Equity Firms and Sources
Published since 1998, VCPro
Database is the most reliable, up-to-date and affordable venture
capital directory
VCPro Database 2021
24th Edition --
a downloadable and searchable venture capital database with
6,500+ venture capital and private equity firms
worldwide.
Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital Private Equity To Acquire Partssource | Mcguirewoods Llp
2021-07-23T12:01:05.752975-04:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-bain-capital-private-equity-to-acquire-partssource-mcguirewoods-llp-20210723055/
Bain Capital Private Equity has announced it will acquire PartsSource from Great Hill Partners. PartsSource, based in Aurora, Ohio, is an online marketplace for medical equipment maintenance parts and services....By: McGuireWoods LLP.
Healthcare & Life Sciences Private Equity Deal Tracker: Ascend Partners Invests In Rendr | Mcguirewoods Llp
2021-05-11T14:01:10.481051-04:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-ascend-partners-invests-in-rendr-mcguirewoods-llp-20210511207/
Ascend Partners has completed an equity investment in Rendr, according to a news release. Rendr, based in New York, is multi-specialty physician group serving Asian American patients in New York City....By: McGuireWoods LLP.
Rapha Capital Management Launches $100M Life Science Vc Fund With An Eye On Early Science
2021-04-16T11:01:08.412950-04:00https://www.thetrustedinsight.com/investment-news/rapha-capital-management-launches-100m-life-science-vc-fund-with-an-eye-on-early-science-20210416625/
Rapha Capital Management launches $100M life science VC fund with an eye on early science
badams
Fri, 04/16/2021 - 03:25.:
Life science venture capital firm Rapha Capital Management has launched its first managed venture capital fund with a target raise of $100M and “solely focused” on investment in early-stage life science companies. The money, which is being raised via the so-called Rapha Capital BioVentures Fund I, will focus on securing the investment lead, typically at series A or just before, in target companies and will be managed by Kevin Slawin, M.D., the founder and managing partner of the firm.
Demand For Life Science Real Estate Shows No Sign Of Slowing
2021-04-09T09:31:08.144261-04:00https://www.thetrustedinsight.com/investment-news/demand-for-life-science-real-estate-shows-no-sign-of-slowing-20210409095/
As demand for life science centers continues growing, U.S. metros are avidly vying for life-science prominence, with Charleston, Columbus and Houston all emerging as fast-rising contenders.
Healthcare & Life Sciences Private Equity Deal Tracker: Northlane Capital Invests In Empower Community Care | Mcguirewoods Llp
2021-03-31T16:31:06.042281-04:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-northlane-capital-invests-in-empower-community-care-mcguirewoods-llp-20210331501/
Northlane Capital Partners (NCP) has announced it has completed an investment in Empower Community Care....By: McGuireWoods LLP. :
Northlane Capital Partners (NCP) has announced it has completed an investment in Empower Community Care. Empower, based in Atlanta, is a behavioral health organization that distributes evidence-based programs and technologies. The company provides services in 45 states and 17 countries. Empower is the parent company of MST Services, Orbis Partners and Evidence Based Associates. NCP, based in Bethesda, Md., is a middle market private equity firm focused on healthcare and business services.
Healthcare & Life Sciences Private Equity Deal Tracker: Platinum Equity Acquires Ndc From Court Square Capital Partners | Mcguirewoods Llp
2021-03-11T13:01:06.596291-05:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-platinum-equity-acquires-ndc-from-court-square-capital-partners-mcguirewoods-llp-20210311080/
Platinum Equity has acquired NDC from an affiliate of Court Square Capital Partners, according to a news release....By: McGuireWoods LLP.
Medibuddy Raises $20mn Funding From India Life Sciences Fund Iii, Others | Business Standard News
2021-02-22T09:41:05.933073-05:00https://www.thetrustedinsight.com/investment-news/medibuddy-raises-20mn-funding-from-india-life-sciences-fund-iii-others-business-standard-news-20210222787/
The firm raised $20 million (about Rs 145 crore) earlier this month from India Life Sciences Fund III, LLC and others.
3 Top Life Science Vcs: Why Covid-19 Won't Reshape The Drug Industry
2021-02-16T13:01:05.855524-05:00https://www.thetrustedinsight.com/investment-news/3-top-life-science-vcs-why-covid-19-wont-reshape-the-drug-industry-20210216392/
Summary List PlacementTake all venture capital predictions with a grain of salt, Venrock partner Cami Samuel told Insider. Though Andreessen Horowitz may have predicted a flood of investment dollars in infectious diseases in 2021 inspired by the pandemic in its start-of-year blog post, the early-stage biotech VC is sticking to her guns. Last March, Samuels told TechCrunch that the pandemic likely wouldn't drastically increase investors' interest in infectious diseases. Almost a year later, Samuels told Insider her stance hasn't changed.
Woodford Returns With New Firm Targeting Acacia Life Sciences Portfolio
2021-02-15T11:01:06.124213-05:00https://www.thetrustedinsight.com/investment-news/woodford-returns-with-new-firm-targeting-acacia-life-sciences-portfolio-20210215318/
Neil Woodford has returned 16 months after the collapse of Woodford Investment Management with the launch of a new investment firm, which is working alongside Acacia Research to "advise" on an illiquid and unlisted portfolio of life sciences companies once owned by the Woodford Equity Income fund (WEIF).
Healthcare & Life Sciences Private Equity Deal Tracker: H.i.g. Capital Acquires Crothall Laundry Services | Mcguirewoods Llp
2021-01-05T15:31:06.164032-05:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-hig-capital-acquires-crothall-laundry-services-mcguirewoods-llp-20210105612/
H.I.G. Capital has announced it has completed its acquisition of Crothall Laundry Services....By: McGuireWoods LLP. :
Crothall Laundry Services is a provider of outsourced laundry and linen management services to the healthcare and hospitality markets. Founded in 1991, the company is formerly a Compass Group subsidiary. H.I.G. Capital, based in Miami, pursues a wide range of investments in healthcare and many other industries. Founded in 1993, the firm has flexibility on investment size, including interest in pre-EBITDA businesses. Within healthcare, the firm targets companies in the provider services, hospital/major facilities and life sciences/pharmaceutical industries.
Nference Completes $60M Series C To Accelerate And Expand Augmented Intelligence For Life Sciences
2020-12-15T22:06:11.063169-05:00https://www.thetrustedinsight.com/investment-news/nference-completes-60m-series-c-to-accelerate-and-expand-augmented-intelligence-for-life-sciences-20201215726/
CAMBRIDGE, Mass., December 15, 2020-- nference, which synthesizes the world's biomedical knowledge, announced completion of a $60 million Series C funding round led by Matrix Capital Management, along with Matrix Partners, Mayo Clinic Ventures and NTTVC. "nference – a science-first software company – continues to push the boundaries of augmented intelligence to accelerate the work of our expert scientists and technologists in making biomedical knowledge computable via our nferXTM software platform," said Murali Aravamudan, co-founder and chief executive officer. "This funding enables expansion of our portfolio, which is catalyzing development of meaningful diagnostics and therapeutics.
Healthcare & Life Sciences Private Equity Deal Tracker: Serent Capital Invests In Procurement Partners | Mcguirewoods Llp
2020-12-07T12:01:05.967240-05:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-serent-capital-invests-in-procurement-partners-mcguirewoods-llp-20201207194/
Serent Capital has completed a growth investment in Procurement Partners, according to a news release. Procurement Partners, based in Brookfield, Wis., is a provider of procure-to-pay solutions for healthcare providers....By: McGuireWoods LLP.
Rubedo Life Sciences Closes $12M Seed Financing Led By Khosla Ventures
2020-12-03T21:01:08.484256-05:00https://www.thetrustedinsight.com/investment-news/rubedo-life-sciences-closes-12m-seed-financing-led-by-khosla-ventures-20201203051/
- Company optimizing lead compounds to file IND application and initiate first-in-human clinical trials targeting senescent cells in pulmonary disorders
- Funding will be used to drive R&D, advance clinical pipeline and expand scientific team SUNNYVALE, Calif., December 3, 2020-- Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive age-related diseases, today announced the closing of a $12M Seed financing round. The round was led by Khosla Ventures, with participation from Longevity Fund, Refactor Capital, Shanda and additional investors.
Saudi Firm Signs $225M Deal For Life Science Campus
2020-12-01T11:01:07.449389-05:00https://www.thetrustedinsight.com/investment-news/saudi-firm-signs-225m-deal-for-life-science-campus-20201201857/
Summary List PlacementSidra Capital, a Saudi asset management and private equity firm, purchased a suburban Philadelphia life sciences and healthcare campus in a recapitalization deal that valued the property at $225 million. Spear Street Capital, a real estate investment firm, will retain a 10% minority interest. The deal was brokered by JLL. The five-building, 855,600 square foot Arborcrest facility was completed in two phases, 2015 and 2019, and includes as tenants Signant Health, a clinical trial management company, Pharmaceutical Research Association, a clinical research organization, and Abington Memorial, an outpatient facility.
Healthcare & Life Sciences Private Equity Deal Tracker: Frazier Healthcare Partners Acquires Accuity Delivery Systems | Mcguirewoods Llp
2020-11-02T15:01:09.306895-05:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-frazier-healthcare-partners-acquires-accuity-delivery-systems-mcguirewoods-llp-20201102352/
Frazier Healthcare Partners has announced it has acquired Accuity Delivery Systems....By: McGuireWoods LLP. :
Accuity, based in New York, is a provider of technology-enabled revenue integrity and clinical documentation improvement services for hospitals and health systems. Frazier Healthcare Partners, based in Seattle, is a provider of private equity capital to healthcare companies. The firm, founded in 1991, prefers to make more substantial investments from a dollars perspective and pursues a wide range of investment types, including company creation and venture capital to buyouts of profitable lower-middle market companies.
Gene Therapy Company Aavantibio Launches With $107M Series A Financing From Perceptive Advisors, Bain Capital Life Sciences, Ra Capital Management And Sarepta Therapeutics
2020-10-22T21:31:06.911022-04:00https://www.thetrustedinsight.com/investment-news/gene-therapy-company-aavantibio-launches-with-107m-series-a-financing-from-perceptive-advisors-bain-capital-life-sciences-ra-capital-management-and-sarepta-therapeutics-20201022788/
Healthcare & Life Sciences Private Equity Deal Tracker: Accel-kkr Invests In Surgical Information Systems | Mcguirewoods Llp
2020-10-16T18:31:07.500743-04:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-accel-kkr-invests-in-surgical-information-systems-mcguirewoods-llp-20201016450/
Accel-KKR has made a majority equity investment in Surgical Information Systems (SIS), according to a news release....By: McGuireWoods LLP. :
Accel-KKR has made a majority equity investment in Surgical Information Systems (SIS), according to a news release. SIS, based in Alpharetta, Ga., provides business office management, clinical documentation and patient communications tools for ambulatory surgery centers and anesthesia information management systems and perioperative solutions to hospitals and outpatient surgery departments. Accel-KKR, based in Menlo Park, Calif., is a technology-focused private equity firm.
8 Silicon Valley Law Firms Leading Tech And Life Sciences Practices
2020-10-16T08:31:07.147506-04:00https://www.thetrustedinsight.com/investment-news/8-silicon-valley-law-firms-leading-tech-and-life-sciences-practices-20201016420/
Summary List Placement
The "wild West" days of Silicon Valley are no longer, and law firms have increasingly been turning their attention westward, seeking to establish a presence in the Bay Area amid the tech and life sciences boom. Freshfields announced in July that it will be opening a Silicon Valley office, citing the continuing growth of "the impact and strategic importance of technology and life sciences businesses." Meanwhile, Paul, Weiss, Rifkind, Wharton & Garrison also said that it intends to establish a Northern California office, as previously reported in Bloomberg Law.
Cbre Highlights 6 Markets With Rapidly Growing Life Science Clusters
2020-10-12T19:31:06.479698-04:00https://www.thetrustedinsight.com/investment-news/cbre-highlights-6-markets-with-rapidly-growing-life-science-clusters-20201012157/
Summary List Placement
Real estate to house pharmaceutical, biotech, and other medical research professionals is growing at a rapid pace and rents continue to rise, a sign that tenant demand can support the increasing attention on life sciences from institutional investors and developers. Lab space has grown by 11.9% across the US to 95 million square feet over the 18 months leading up ending on June 31 with another 11 million square feet under construction, according to a CBRE report detailing growth in the largest biotech clusters. The sector has added more than 20 million square feet of space over the last 2 years.
Rediscovery Life Sciences Completes $4.5M Series B Financing
2020-09-23T23:31:06.402217-04:00https://www.thetrustedinsight.com/investment-news/rediscovery-life-sciences-completes-45m-series-b-financing-20200923168/
RALEIGH, N.C., September 23, 2020-- Rediscovery Life Sciences, LLC (RLS), a clinical-stage biotechnology company, announced the closing of its most recent financing. The Series B financing was co-led by REX Health Ventures (the investment arm of UNC REX Healthcare) and Orlando Health Ventures. RLS will use the proceeds to fund a Phase 2 trial of suramin in diuretic resistant Acute Kidney Injury (AKI). Anita Watkins, JD, Director of REX Health Ventures, and Dr. Sunil Desai, President of the Orlando Health Medical Group, have joined RLS's Board of Directors.
Healthcare & Life Sciences Private Equity Deal Tracker: Ta Associates And Francisco Partners Invest In Edifecs | Mcguirewoods Llp
2020-08-04T14:31:06.847020-04:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-ta-associates-and-francisco-partners-invest-in-edifecs-mcguirewoods-llp-20200804555/
TA Associates and Francisco Partners have signed a definitive agreement to make a significant growth investment in Edifecs, according to a news release....By: McGuireWoods LLP.
Healthcare & Life Sciences Private Equity Deal Tracker: Ew Healthcare Partners Leads Investment In Cardiva Medical | Mcguirewoods Llp
2020-07-20T15:31:05.990201-04:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-ew-healthcare-partners-leads-investment-in-cardiva-medical-mcguirewoods-llp-20200720806/
EW Healthcare Partners has led a $45 million equity financing round into Cardiva Medical, according to a news release....By: McGuireWoods LLP.
Healthcare & Life Sciences Private Equity Deal Tracker: Accel-kkr Invests In Forcura | Mcguirewoods Llp
2020-07-17T16:01:07.346939-04:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-accel-kkr-invests-in-forcura-mcguirewoods-llp-20200717711/
Accel-KKR has made a “significant” growth investment in healthcare technology company Forcura, according to a news release....By: McGuireWoods LLP. :
Accel-KKR has made a “significant” growth investment in healthcare technology company Forcura, according to a news release. Forcura, based in Jacksonville, Fla., is a developer of document management and communication solutions for home health and hospice organizations. Accel-KKR, based in Menlo Park, Calif., is a technology-focused investment firm. The firm pursues middle-market companies and provides a broad range of capital solutions, including buyout capital, minority-growth investments and credit alternatives.
Innovatus Appoints Geoffrey Duyk, M.d., Ph.d. To Its Life Sciences Advisory Board
2020-06-22T08:31:06.359894-04:00https://www.thetrustedinsight.com/investment-news/innovatus-appoints-geoffrey-duyk-md-phd-to-its-life-sciences-advisory-board-20200622037/
NEW YORK--(BUSINESS WIRE)--Innovatus Capital Partners, LLC ("Innovatus" or the "Firm"), an independent adviser and portfolio management firm with approximately $1.6 billion in assets under management, today announced that it has appointed Geoffrey Duyk, M.D., Ph.D., the founder and Managing Partner of Circularis LP, to its Life Sciences Advisory Board. Headquartered in New York, Innovatus Capital Partners’ Life Sciences strategy (“Innovatus Life Sciences”) provides growth capital in the form of.
Orbita Raises $9M To Accelerate Conversational Ai Solutions In Healthcare And Life Sciences
2020-05-28T21:01:06.351439-04:00https://www.thetrustedinsight.com/investment-news/orbita-raises-9m-to-accelerate-conversational-ai-solutions-in-healthcare-and-life-sciences-20200528487/
Round co-led by Philips Health Technology Ventures and HealthX Ventures along with investors Cultivation Capital and Newark Venture Partners BOSTON, May 28, 2020-- Orbita, the leading provider of conversational AI-powered voice and chatbot solutions for healthcare, announced today that it has secured $9M of venture funding as part of the company's Series A financing round. Co-leading the round are Philips Health Technology Ventures, which manages a business-agnostic fund investing in future partners to drive Philips' digital transformation, and HealthX Ventures, a digital healthcare-focused venture capital firm. Cultivation Capital and Newark Venture Partners also participated in the round.
Calcimedica Raises $15M In Series C Financing Round Led By Valence Life Sciences
2020-05-22T21:41:06.238810-04:00https://www.thetrustedinsight.com/investment-news/calcimedica-raises-15m-in-series-c-financing-round-led-by-valence-life-sciences-20200522158/
Funds to support ongoing clinical trials in patients with COVID-19 pneumonia and commercial manufacturing of Auxora™ LA JOLLA, Calif., May 22, 2020-- CalciMedica Inc. (“CalciMedica” or the “Company), a clinical-stage biotechnology company targeting calcium release-activated calcium (CRAC) channels for the treatment of acute and severe inflammatory diseases, today announced it has raised $15 million in a Series C financing round. The round was led by Valence Life Sciences, LLC with participation from new investors Bering Capital, Mesa Verde Venture Partners and existing investor Sanderling Ventures.
Calico Life Sciences Founder Says He's 'disappointed' With Progress
2020-05-21T19:01:07.004017-04:00https://www.thetrustedinsight.com/investment-news/calico-life-sciences-founder-says-hes-disappointed-with-progress-20200521062/
Bill Maris, who founded Google Ventures and left to build his own investment fund called Section 32, just brought aboard several former Googlers to his new company. Among those is Claire Stapleton, a previous YouTube executive who led an employee walkout at Google in 2018 to protest the company's handling of sexual-misconduct allegations. Maris also founded Calico, the secretive life-sciences company that still sits under Alphabet. He said he's "disappointed" with the lack of progress Calico has shown since his departure. Click here to get BI Prime's weekly "Trending" tech newsletter in your email inbox.
Frazier Healthcare Partners Adds Experienced Capital Markets Executive To Life Sciences Team
2020-04-29T07:01:09.487412-04:00https://www.thetrustedinsight.com/investment-news/frazier-healthcare-partners-adds-experienced-capital-markets-executive-to-life-sciences-team-20200429376/
MENLO PARK, Calif., April 28, 2020-- Frazier Healthcare Partners announced David Topper has joined the Life Sciences team as a Senior Advisor. He has over 35 years of experience in the capital markets. Mr. Topper was formerly the global head of capital markets at a major growth equity investment firm. Prior to that, he was Co-Head of Equity Capital Markets at J.P. Morgan, where he led the firm’s major advisory and capital-raising transactions and worked with the U.S. Treasury and other regulatory agencies on crisis-related issues. He also served as Chairman of the Commitments Committee at J.P. Morgan.
Xconomy: Life Science A Vc Bright Spot In Q1, But Startups May Soon Struggle
2020-04-23T10:31:07.579191-04:00https://www.thetrustedinsight.com/investment-news/xconomy-life-science-a-vc-bright-spot-in-q1-but-startups-may-soon-struggle-20200423033/
Even as the novel coronavirus has derailed daily life and business operations, the life sciences sector continues to see companies make public debuts and ink both financing and partnership deals. In venture capital, US deal activity in the first quarter tallied 2,300 financings totaling $34.2 billion, according to the latest report by the National Venture […]
Healthcare & Life Sciences Private Equity Deal Tracker: Newspring And Veronis Suhler Stevenson Invest In Brc Recovery | Mcguirewoods Llp
2020-04-14T15:01:06.988512-04:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-newspring-and-veronis-suhler-stevenson-invest-in-brc-recovery-mcguirewoods-llp-20200414348/
NewSpring Health Capital and Veronis Suhler Stevenson (VSS) announced the completion of an investment in BRC Recovery Family of Programs (BRC)....By: McGuireWoods LLP.
China Digest: Ribo Life Science Nets $60m; Qst Raises $49M
2020-04-06T07:16:08.254637-04:00https://www.thetrustedinsight.com/investment-news/china-digest-ribo-life-science-nets-60m-qst-raises-49m-20200406830/
China's Ribo Life Science has collected $66 million in a Series C2 round of financing. The post China Digest: Ribo Life Science nets $60m; QST raises $49m appeared first on DealStreetAsia.
Life Sciences Investor Sosv Looks For Start-ups Focused On Covid-19 Solutions | Venture Capital Journal
2020-03-24T09:01:05.530234-04:00https://www.thetrustedinsight.com/investment-news/life-sciences-investor-sosv-looks-for-start-ups-focused-on-covid-19-solutions-venture-capital-journal-20200324038/
SOSV's labs, which have remained open during the national lockdown, have already worked with more than a dozen start-ups on the front lines of the covid-19 response. Not yet registered? Join today to access Venture Capital Journal's industry insights and updates.
Healthcare & Life Sciences Private Equity Deal Tracker: Arsenal Capital Acquires Bresmed | Mcguirewoods Llp
2020-02-27T16:01:07.276400-05:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-arsenal-capital-acquires-bresmed-mcguirewoods-llp-20200227398/
Arsenal Capital Partners has announced it acquired BresMed Health Solutions....By: McGuireWoods LLP. :
BresMed, with its U.S. office in Las Vegas, Nev., is a health economic and outcomes research consultancy that provides health economic solutions to the global pharmaceutical industry. Arsenal, based in New York, is a private equity firm specializing in investments in middle market healthcare and specialty industrials companies. Founded in 2000, the firm seeks control investments in companies with the capacity to use $50 million to $300 million of equity, including add-on acquisitions.
Three Years After Raising $450 Million, Andreessen Is Back With A New $750M Life Sciences Fund – Techcrunch
2020-02-05T06:11:07.657349-05:00https://www.thetrustedinsight.com/investment-news/three-years-after-raising-450-million-andreessen-is-back-with-a-new-750m-life-sciences-fund-techcrunch-20200205737/
Life sciences is big business in venture capital land and firms are raising big dollars to find the companies that will lead the next healthcare revolution. Chief among them is Andreessen Horowitz, which announced its third life sciences fund with a $750 million final close earlier today. Andreessen went back to market less than than […]
Benchsci Raises $22 Million Series B And Launches New Ai-assisted Reagent Selection Product To Optimize $10.2B In Life Science R&d Spend
2020-02-04T22:11:07.594563-05:00https://www.thetrustedinsight.com/investment-news/benchsci-raises-22-million-series-b-and-launches-new-ai-assisted-reagent-selection-product-to-optimize-102b-in-life-science-rd-spend-20200204710/
BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend F-Prime Capital led the round with participation from existing investors including Gradient Ventures, Google’s AI fund. TORONTO, February 4, 2020-- BenchSci, which uses machine learning to identify and resolve preclinical research inefficiencies in drug discovery, announced today it has raised $22 million in Series B financing, launched its new AI-Assisted Reagent Selection product, and expanded its contract with Novartis in a market worth more than $10.2 billion per year in life science R&D cost-saving opportunities.
Blackstone Raises Three-quarters Of Targeted $4.6B Life Sciences Fund | News | The Mighty 790 Kfgo
2020-01-12T06:01:07.033568-05:00https://www.thetrustedinsight.com/investment-news/blackstone-raises-three-quarters-of-targeted-46b-life-sciences-fund-news-the-mighty-790-kfgo-2kTbrqaJtU7fAiEDWZUt4G-20200112999/
(Reuters) - U.S. private equity firm Blackstone Group Inc has secured $3.4 billion from investors for its first fund dedicated to investments in the life sciences sector, targeting $4.6 billion in total, a regulatory filing showed on Thursday. At its target fundraising amount, the fund would be one of the biggest in the sector. The raise underscores investors' strong appetite for the lucrative returns associated with the development of high-impact drugs, as well as their tolerance for risk, given that a therapy's success is far from certain.
Blackstone Raises Three-quarters Of Targeted $4.6B Life Sciences Fund
2020-01-09T19:01:05.528885-05:00https://www.thetrustedinsight.com/investment-news/blackstone-raises-three-quarters-of-targeted-46b-life-sciences-fund-fgnxCKCdkWKPsUuYZnSxgc-20200109863/
Private equity firm Blackstone Group Inc has secured $3.4 billion from investors for its first fund dedicated to investments in the life sciences sector, targeting $4.6 billion in total, a regulatory filing showed on Thursday.
Blackstone Raises Three-quarters Of Targeted $4.6B Life Sciences Fund
2020-01-09T18:31:06.291156-05:00https://www.thetrustedinsight.com/investment-news/blackstone-raises-three-quarters-of-targeted-46b-life-sciences-fund-20200109860/
Private equity firm Blackstone Group Inc
has secured $3.4 billion from investors for its first
fund dedicated to investments in the life sciences sector,
targeting $4.6 billion in total, a regulatory filing showed on
Thursday.
Blackstone Raises Three-quarters Of Targeted $4.6B Life Sciences Fund | News | The Mighty 790 Kfgo
2020-01-09T18:01:05.481567-05:00https://www.thetrustedinsight.com/investment-news/blackstone-raises-three-quarters-of-targeted-46b-life-sciences-fund-news-the-mighty-790-kfgo-20200109858/
(Reuters) - Private equity firm Blackstone Group Inc has secured $3.4 billion from investors for its first fund dedicated to investments in the life sciences sector, targeting $4.6 billion in total, a regulatory filing showed on Thursday. The fund is one of the biggest such funds in the sector. The raise underscores investors' strong appetite for the lucrative returns associated with the development of high-impact drugs, as well as their tolerance for risk given that a therapy's success is far from certain.
Transcenta Raises $100M Led By Fortune Capital, Cr-cp Life Science Fund
2020-01-08T06:11:06.765880-05:00https://www.thetrustedinsight.com/investment-news/transcenta-raises-100m-led-by-fortune-capital-cr-cp-life-science-fund-20200108675/
The round comes a year after Temasek-backed HJB agreed to merge with MabSpace to set up Transcenta. The post Transcenta raises $100m led by Fortune Capital, CR-CP Life Science Fund appeared first on DealStreetAsia.
Healthcare & Life Sciences Private Equity Deal Tracker: Ew Healthcare Partners Invests In Sonendo | Mcguirewoods Llp
2020-01-07T15:31:07.466829-05:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-ew-healthcare-partners-invests-in-sonendo-mcguirewoods-llp-20200107620/
EW Healthcare Partners has led an $85 million financing round for Sonendo, according to a news release. Sonendo, based in Laguna Hills, Calif., is a dental technology company....By: McGuireWoods LLP.
Breakthrough Prize Opens Public Nominations For Its 2021 Prizes In Fundamental Physics, Life Sciences & Mathematics
2019-12-09T12:01:06.344183-05:00https://www.thetrustedinsight.com/investment-news/breakthrough-prize-opens-public-nominations-for-its-2021-prizes-in-fundamental-physics-life-sciences-mathematics-20191209658/
SAN FRANCISCO, Dec. 9, 2019 /PRNewswire/ -- The public nomination period for the 2021 Breakthrough Prizes in Fundamental Physics, Life Sciences and Mathematics is now open. Prizes will be awarded in late 2020, during a live, globally televised gala awards ceremony in Silicon Valley....
Jdrf T1d Fund Appoints Veteran Life Sciences Executive Dr. Steven St. Peter As Managing Director
2019-10-23T22:01:06.604637-04:00https://www.thetrustedinsight.com/investment-news/jdrf-t1d-fund-appoints-veteran-life-sciences-executive-dr-steven-st-peter-as-managing-director-20191023626/
Seasoned Investor and Operating Executive Brings Diverse Experience to Advance Venture Philanthropy Fund’s Mission BOSTON, October 23, 2019-- The JDRF T1D Fund, the venture philanthropy fund focused on accelerating life-changing solutions to cure, prevent, and treat type 1 diabetes (T1D) through catalytic investments, today announced the expansion of its investment team with the addition of Steven St. Peter, M.D., as a Managing Director.
Ditch The VC: Alternative Funding Options For Biotech Startups
2019-09-17T08:18:20.337318-04:00https://www.thetrustedinsight.com/investment-news/ditch-the-vc-alternative-funding-options-for-biotech-startups-20190917171/
Getting money for a biotech startup can be a daunting task. Venture capital is not the only — and not always the best — option to fund a life sciences company.
‘mega Block’ In Amazon’s Backyard Will Become A Life Sciences Campus Following $143.5M Deal; Proceeds To Fund Affordable Housing – Geekwire
2019-08-07T19:01:05.379706-04:00https://www.thetrustedinsight.com/investment-news/mega-block-in-amazons-backyard-will-become-a-life-sciences-campus-following-1435m-deal-proceeds-to-fund-affordable-housing-geekwire-20190807065/
One of the last big chunks of land in the booming Seattle neighborhood of South Lake Union will turn into a life sciences hub — with proceeds of the sale helping fund affordable housing and homelessness issues. The City of Seattle announced today that it will sell the so-called Mercer Mega Block to Alexandria Real Estate Equities, a developer of biotech and life sciences spaces.
Kbl Merger Corp. Iv Spac Signs Definitive Business Combination Agreement To Acquire Cannbiorx Life Sciences Corp.
2019-07-26T09:31:05.658320-04:00https://www.thetrustedinsight.com/investment-news/kbl-merger-corp-iv-spac-signs-definitive-business-combination-agreement-to-acquire-cannbiorx-life-sciences-corp-20190726996/
NEW YORK, July 26, 2019 /PRNewswire/ -- KBL Merger Corp. IV (NASDAQ: KBLM) ("KBLM"), a Special Purpose Acquisition Company (SPAC), announced today that it has executed a definitive business combination agreement for the merger of a wholly owned subsidiary of KBLM with CannBioRx Life...
Omega Capital And Oklahoma Life Science Fund Announce Recapitalization Of Careatc, Leader In Employee Population Health Management
2019-06-06T07:01:05.076183-04:00https://www.thetrustedinsight.com/investment-news/omega-capital-and-oklahoma-life-science-fund-announce-recapitalization-of-careatc-leader-in-employee-population-health-management-fed2Byf2HBRxpZE8iVRpiQ-20190606442/
Omega Capital and Oklahoma Life Science Fund Announce Recapitalization of CareATC, Leader in Employee Population Health Management TULSA, Okla., June 5, 2019-- Oklahoma-based Omega Capital and the Oklahoma Life Science Fund announce the recent growth recapitalization of CareATC, Inc. by LLR Partners, a middle market private equity firm in Philadelphia. Terms of the transaction were not disclosed. Tulsa-based CareATC, Inc. is a technology-driven employee population health management company founded by Ron Woods in 2000. Omega Capital and the Oklahoma Life Science Fund provided the company's first institutional capital in 2014.
Storm Therapeutics Extends Series A To GBP 30m (usd 38.43m) With New Investor, Seroba Life Sciences
2019-05-20T23:06:06.332264-04:00https://www.thetrustedinsight.com/investment-news/storm-therapeutics-extends-series-a-to-gbp-30m-usd-3843m-with-new-investor-seroba-life-sciences-20190520147/
CAMBRIDGE, England, May 20, 2019-- STORM Therapeutics ("STORM"), the drug discovery company tackling disease through modulating RNA modifying enzymes, today announced that it has raised an additional £14 million bringing the total Series A financing to £30 million. The financing includes funding from new investor, Seroba Life Sciences ("Seroba"). STORM's existing investors, Cambridge Innovation Capital, M Ventures, Pfizer Ventures, Taiho Ventures and IP Group also participated in the fundraise. This extension follows the company's rapid progress to date.
Sirnaomics In Raises $22M Led By Hong Kong's Cr-cp Life Sciences Fund
2019-05-02T09:31:04.672223-04:00https://www.thetrustedinsight.com/investment-news/sirnaomics-in-raises-22m-led-by-hong-kongs-cr-cp-life-sciences-fund-20190502562/
Other investors joining the round are Shanghai-based Rich Yield Capital, Rolling Boulder Investment from Shenzhen and US-based Legend Sky Investment. The post Sirnaomics In raises $22m led by Hong Kong’s CR-CP Life Sciences Fund appeared first on DealStreetAsia.
Here’s How Early-stage Investors See The Northwest’s Life Science Market – Geekwire
2019-04-27T14:01:04.921082-04:00https://www.thetrustedinsight.com/investment-news/heres-how-early-stage-investors-see-the-northwests-life-science-market-geekwire-20190427158/
Hey investors, how does the Pacific Northwest stack up in life sciences? It’s a loaded question, given that venture capitalists invested far less in the Pacific Northwest in 2018 than leading regions in terms of total investment, number of deals and deal size. The average deal size in San Francisco and New England last year was around $60 million, double the roughly $30 million average that Northwest companies saw, according to data presented by Karen Bernstein, co-founder of BioCentury, at the 2019 Life Science Innovation Northwest conference in Seattle earlier this week.
Xconomy: Hatteras Launches New Fund With $94M For Life Science Investments
2019-04-15T09:01:05.878801-04:00https://www.thetrustedinsight.com/investment-news/xconomy-hatteras-launches-new-fund-with-94m-for-life-science-investments-20190415116/
Hatteras Venture Partners is kicking off its latest fund with $94 million it plans to deploy to life sciences startups. The cash committed so far is the first closing of a fund that Hatteras says could reach up to $200 million. It’s the sixth fund for Durham, NC-based Hatteras. The venture capital firm invests throughout […]
Xconomy: San Diego Life Sciences Roundup: Evofem, Cullgen, Brainleap & More
2019-04-12T07:01:04.167207-04:00https://www.thetrustedinsight.com/investment-news/xconomy-san-diego-life-sciences-roundup-evofem-cullgen-brainleap-more-20190412958/
Locally based biotech companies receive fresh funding from investors. A software startup launches games that it says may help children with disorders that cause attention difficulties. Get the details on these developments and more in San Diego life sciences news: —Evofem Biosciences (NASDAQ: EVFM) struck a deal to raise up to $80 million in a […]
Blackstone Life Sciences And Novartis To Launch Cardiovascular Drug Company
2019-02-27T08:01:06.398489-05:00https://www.thetrustedinsight.com/investment-news/blackstone-life-sciences-and-novartis-to-launch-cardiovascular-drug-company-20190227223/
The life sciences business of Manhattan-based Blackstone Group is making its first investment, spending $250 million to form a company with drugmaker Novartis, called Anthos Therapeutics, that will...
To view the full story, click the title link.
Tiger Global, Softbank Invest In Chinese Life Science Solutions Provider Taimei Technology – China Money Network
2019-01-28T06:06:07.077902-05:00https://www.thetrustedinsight.com/investment-news/tiger-global-softbank-invest-in-chinese-life-science-solutions-provider-taimei-technology-china-money-network-20190128658/
Chinese life science technology solutions provider Taimei Technology has secured a US$80 million series E round of financing led by Tiger Global Management, said Taimei Technology at its annual meeting on January 25. Softbank China and Chinese healthcare-focused venture capitalist Cowin Venture also participated in the round.
Alphabet's Life Science Tech Unit Verily Raises $1B From Investors
2019-01-03T19:01:04.147293-05:00https://www.thetrustedinsight.com/investment-news/alphabets-life-science-tech-unit-verily-raises-1b-from-investors-20190103718/
Verily, Alphabet Inc's life
sciences division, on Thursday announced a $1 billion investment
round led by private equity firm Silver Lake. :
(Reuters) - Verily, Alphabet Inc’s (GOOGL.O) life sciences division, on Thursday announced a $1 billion investment round led by private equity firm Silver Lake. Alphabet Chief Financial Officer Ruth Porat and Silver Lake Managing Director Egon Durban will be nominated to Verily’s operating board, the company said. Verily’s existing board members include Chief Executive Andrew Conrad, Alphabet executives Larry Page, Sergey Brin and David Drummond and Temasek senior managing director Fidah Alsagoff, a company spokeswoman said.
Digital Health Megadeals Get Bigger In Q3 2018 | Fenwick & West Life Sciences Group
2018-11-13T15:01:04.349452-05:00https://www.thetrustedinsight.com/investment-news/digital-health-megadeals-get-bigger-in-q3-2018-fenwick-west-life-sciences-group-20181113968/
Just over a year ago, we reported about the rise of the mega-round in digital health investments. At that time, we tallied nine investment rounds valued at more than $100 million in the first half of 2017....By: Fenwick & West Life Sciences Group.
Blackstone Buys Clarus To Bulk Up In Life Sciences
2018-10-04T16:31:07.019949-04:00https://www.thetrustedinsight.com/investment-news/blackstone-buys-clarus-to-bulk-up-in-life-sciences-20181004441/
Blackstone Group LP said on
Thursday it has agreed to acquire life sciences investment firm
Clarus, in an effort by the world's largest alternative asset
manager to scale up its investments in healthcare.
Anju Software Harnesses The Power Of Life Sciences Data Through Acquisition Of Zephyr Health
2018-10-02T18:31:04.650359-04:00https://www.thetrustedinsight.com/investment-news/anju-software-harnesses-the-power-of-life-sciences-data-through-acquisition-of-zephyr-health-20181002179/
NEW YORK--(BUSINESS WIRE)--Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, today announced that it has acquired San Francisco-based Zephyr Health, a company that provides comprehensive physician, institution and treatment data for every major disease area. Zephyr uses proprietary algorithms to link disparate data sources delivering actionable insights. With this acquisition, Anju continues to execute on combining robust software with actionable data t.
Xconomy: 3 Life Science Startups Join San Diego's Ad Astra Accelerator
2018-09-19T19:01:04.882292-04:00https://www.thetrustedinsight.com/investment-news/xconomy-3-life-science-startups-join-san-diegos-ad-astra-accelerator-20180919984/
Three San Diego life science startups have been selected to go through the Ad Astra Ventures accelerator program, a relatively new addition to the San Diego scene. Ad Astra, which means “to the stars” in Latin, was founded this year by three local entrepreneurs and investors interested in bolstering the efforts of women-led companies. Earlier […]
Digital Health Investment Trends Q2 2018: Megadeals Become The Norm, China Rising | Fenwick & West Life Sciences Group
2018-07-24T07:06:06.600809-04:00https://www.thetrustedinsight.com/investment-news/digital-health-investment-trends-q2-2018-megadeals-become-the-norm-china-rising-fenwick-west-life-sciences-group-20180724010/
Private investment in digital health continued apace in the second quarter of 2018, based on our latest look at deal flow. As the sector has matured, growth in investment levels quarter-over-quarter and year-over-year appears sustainable for the...By: Fenwick & West Life Sciences Group.
Healthcare & Life Sciences Private Equity Deal Tracker: Cybermdx Raises $10m | Mcguirewoods Llp
2018-07-20T15:31:04.587691-04:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-cybermdx-raises-10m-mcguirewoods-llp-20180720819/
CyberMDX has announced it has raised $10 million in series A financing. The funding round was led by Pitango Venture Capital. CyberMDX, based in New York, is a provider of medical cybersecurity....By: McGuireWoods LLP.
Benchling Raises $14.5m From Benchmark To Advance Life Sciences Research
2018-06-14T22:01:06.066783-04:00https://www.thetrustedinsight.com/investment-news/benchling-raises-145m-from-benchmark-to-advance-life-sciences-research-20180614810/
Benchling Raises $14.5M From Benchmark to Advance Life Sciences Research
Announces 500% ARR Growth and more than 100,000 scientists using its platform
SAN FRANCISCO, June 14, 2018-- Today Benchling, the data management and collaboration platform built to advance life sciences research, announced it has closed $14.5M in Series B funding. The round was led by Benchmark, with participation from F-Prime Capital, a global venture capital firm associated with Fidelity Investments, and returning investor Thrive Capital. Benchmark General Partner Eric Vishria will be joining the board of directors.
Healthcare & Life Sciences Private Equity Deal Tracker: Parachute Health Secures $9.5m In Funding | Mcguirewoods Llp
2018-06-08T13:11:21.406388-04:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-parachute-health-secures-95m-in-funding-mcguirewoods-llp-20180608289/
Parachute Health has announced it has secured $9.5 million in new funding. The funding round was led by Harley Miller and Dan Ahrens of Insight Venture Partners and includes investments from GNYHA Ventures, the business arm of the Greater New York...By: McGuireWoods LLP.
Water Street And Jll Recruit Mark Thierer To Chairman And Jim Lang To Ceo Of Global Life Sciences
2018-06-05T12:31:23.995583-04:00https://www.thetrustedinsight.com/investment-news/water-street-and-jll-recruit-mark-thierer-to-chairman-and-jim-lang-to-ceo-of-global-life-sciences-20180605918/
CHICAGO and NEW YORK, June 5, 2018 /PRNewswire/ -- Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, and JLL Partners, a leading middle-market private equity firm, announced today that they have recruited Mark Thierer to chairman and...
Investors Make Big Bets On Diagnostics In Q1 2018 | Fenwick & West Life Sciences Group
2018-05-02T21:31:04.907682-04:00https://www.thetrustedinsight.com/investment-news/investors-make-big-bets-on-diagnostics-in-q1-2018-fenwick-west-life-sciences-group-20180502881/
Two trends stood out in our analysis of private digital health investments in the first quarter of 2018: bigger deals and more investment in companies targeting the regulated portion of the health care market....By: Fenwick & West Life Sciences Group.
Healthcare & Life Sciences Private Equity Deal Tracker: Tpg Capital, Welsh, Carson, Anderson & Stowe And Humana To Acquire Curo Health Services | Mcguirewoods Llp
2018-05-02T16:01:05.480257-04:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-tpg-capital-welsh-carson-anderson-stowe-and-humana-to-acquire-curo-health-services-mcguirewoods-llp-20180502718/
Private equity firms TPG Capital and Welsh, Carson, Anderson & Stowe (WCAS) are joining with Humana to acquire CURO Health Services for approximately $1.4 billion, according to a news release....By: McGuireWoods LLP.
Jll And Water Street Announce Acquisition To Expand Global Life Sciences Commercialization Services Platform
2018-04-19T07:06:09.637351-04:00https://www.thetrustedinsight.com/investment-news/jll-and-water-street-announce-acquisition-to-expand-global-life-sciences-commercialization-services-platform-20180419759/
JLL and Water Street Announce Acquisition to Expand Global Life Sciences Commercialization Services Platform
CHICAGO and NEW YORK, April 18, 2018-- Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, and JLL Partners, a leading middle-market private equity firm, announced today that they have signed an agreement to acquire Triplefin. An industry leader in patient support for more than 30 years, Triplefin is the latest company to join the investment firms' growing life sciences commercialization services platform. The addition of Triplefin to the life sciences platform will significantly expand the platform's patient-centered capabilities.
Alphabet Gv Life Sciences And Health Investments Going Public
2018-03-30T15:01:04.059298-04:00https://www.thetrustedinsight.com/investment-news/alphabet-gv-life-sciences-and-health-investments-going-public-20180330071/
Alphabet's venture capital investment arm, GV, has seen four of its portfolio companies go public in the last year. :
As the first quarter comes to a close, three Bay Area life sciences companies have already gone public in 2018. The company's venture arm, GV (formerly known as Google Ventures), has backed nearly 60 healthcare-related companies since it raised its first fund in 2009, making it one of the most active Silicon Valley players in the space. Those bets are starting to pay off: Five of GV's healthcare bets have gone public in the last year.
Healthcare & Life Sciences Private Equity Deal Tracker: Riccobene Associates Partners With The Beekman Group | Mcguirewoods Llp
2018-03-27T11:31:05.411721-04:00https://www.thetrustedinsight.com/investment-news/healthcare-life-sciences-private-equity-deal-tracker-riccobene-associates-partners-with-the-beekman-group-mcguirewoods-llp-20180327768/
The Beekman Group has announced it has partnered with Riccobene Associates Family Dentistry. The Beekman Group, based in New York, is a private equity firm that seeks investments in lower middle-market companies in several industries, including...By: McGuireWoods LLP.
Jll Partners And Water Street Healthcare Partners Complete Acquisition To Expand Life Sciences
2018-03-19T13:01:05.703186-04:00https://www.thetrustedinsight.com/investment-news/jll-partners-and-water-street-healthcare-partners-complete-acquisition-to-expand-life-sciences-20180319073/
CHICAGO and NEW YORK, March 19, 2018 /PRNewswire/ -- Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, and JLL Partners, a leading middle-market private equity firm, announced today that they have completed their acquisition of Dohmen...